Edwin Burgstaler^1*, Luis F. Porrata, MD², Jeffrey L. Winters, MD³, Eapen K. Jacob, MD⁴, David J. Inwards, MD², Stephen M. Ansell, MD, PhD¹, Ivana Micallef, MD², Patrick B. Johnston, MD/ PhD⁵, Jose C Villasboas, MD², Jonas Paludo, MD² and Svetomir N. Markovic, MD, PhD⁶

¹Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN
⁵Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁶Division of Medical Oncology, Mayo Clinic, Rochester, MN

Neeraj Saini, MD¹, Junsheng Ma, MS^2*, Qaiser Bashir, MD³, Ruby Delgado^3*, Gabriela Rondon³, Uday R. Popat, MD⁴, Chitra Hosing, MD³, Yago Nieto, MD³, Partow Kebriaei, MD⁵, Amin M. Alousi, MD⁶, Rohtesh S. Mehta, MD, MPH, MS⁴, Samer A. Srour, MD, MS⁴, Issa F. Khouri, MD³, Donna M. Weber, MD⁷, Sheeba K. Thomas, MD⁸, Hans C. Lee, MD⁹, Krina K. Patel, M.D.¹⁰, Robert Z. Orlowski, MD, PhD⁷, Richard E. Champlin, MD³ and Muzaffar H. Qazilbash, MD⁵

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center., Houston, TX
²Department of Statistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁹The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Christopher Lemieux, MD¹, Juliana Craig, BA^1*, David Iberri, MD¹, Sally Arai, MD, MS¹, Laura J. Johnston, MD¹, Robert Lowsky, MD, FRCP¹, Lori Muffly, MD, MS², Parveen Shiraz, MD¹, Michaela Liedtke, MD³, Andrew R. Rezvani, MD¹, Matthew J. Frank, MD, PhD¹, Wen-Kai Weng, MD, PhD¹, Everett H Meyer, MD, PhD^1*, Judith A Shizuru, MD, PhD¹, Robert S. Negrin, MD¹, David B. Miklos, MD, PhD¹ and Surbhi Sidana, MD¹

¹Stanford University School of Medicine, Stanford, CA
²Assistant Professor of Medicine, Stanford University School of Medicine, Stanford, CA
³Division of Hematology, Stanford University School of Medicine, Stanford, CA

Iuliana Vaxman, MD^1,2,3, Alissa Visram, MD^4*, Shaji K. Kumar, MD¹, Angela Dispenzieri, MD⁵, Francis K. Buadi, MB, CHB^4*, David Dingli, MD, PhD¹, Martha Q. Lacy, MD¹, Eli Muchtar, MD^1*, Prashant Kapoor, MD¹, William J Hogan, MB, BCh¹, Suzanne R. Hayman, MD⁴, Nelson Leung, MD¹, Wilson I Gonsalves, MD⁴, Taxiarchis Kourelis, MD¹, Rahma M Warsame, MD⁵, Tamar Berger, MD^6,7* and Morie Gertz¹

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah- Tikva, Israel
³Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, MN
⁶Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel
⁷Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel, Israel

Huimin Liu^1*, Wei Liu^2*, Ru Li^1*, Wenyang Huang^3*, Shuhua Yi, MD^1*, Ryu Lv^1*, Shuhui Deng, MD^1*, Gang An^1*, Lugui Qiu, MD¹ and Dehui Zou, MD^1*

¹lymphoma and myeloma center, National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
³National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Thomas Chalopin^1*, Nicolas Vallet, MD^1*, Marlene Ochmann, MD^2*, Mourad Tiab^3*, Pascal Godmer^4*, Carole Barin^5*, Olivier Theisen, MD^6*, Olivier Herault, MD, PhD^7,8, Emmanuel Gyan, MD, PhD^1,7, Lotfi Benboubker, MD^1*, Philippe Moreau^9,10*, Herve Avet-Loiseau¹¹ and Cyrille Touzeau^9,12,13*

¹Department of Hematology and Cellular Therapy, Tours University Hospital, UMR CNRS, François Rabelais University, Tours, France
²Hospital of Orleans, Hematology department, Orleans, France
³CH la Roche Sur Yon, La Roche Sur Yon Cedex 9, France
⁴Clinical Hematology, Centre Hospitalier Bretagne Atlantique, Vannes, France
⁵Centre Hospitalier universitaire de Tours, Laboratoire de Cytogénétique, Tours, France
⁶Hematology Biology, Nantes University Hospital, Nantes, France
⁷CNRS ERL 7001 LNOx "Leukemic Niche & Redox Metabolism", Tours, France
⁸Service d'Hématologie Biologique, Centre Hospitalier Universitaire, Tours, France
⁹CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France
¹⁰Department of Hematology, University Hospital of Nantes, Nantes, France
¹¹Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France
¹²Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
¹³Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France

Yago Nieto, MD¹, Stephen K. Gruschkus, PhD, MPH^2*, Roy B. Jones, MD, PhD^1*, Benigno C. Valdez, PhD¹, Melissa Timmons, PA-C^1*, Chitra Hosing, MD³, Paolo Anderlini¹, Partow Kebriaei, MD¹, Uday R. Popat, MD¹, Muzaffar H. Qazilbash, MD¹, Amin M. Alousi, MD⁴, Samer A. Srour, MD, MS¹, Neeraj Saini, MD³, Jeremy Ramdial, MD³, Jin S. Im¹, Elizabeth J. Shpall, MD³, Katayoun Rezvani, MD, PhD³, Alison Gulbis^5*, Terri Lynn Shigle, PharmD^6*, Kris Michael Mahadeo, MD⁷, Sajad Khazal, MD⁷, Issa F. Khouri, MD³, Bouthaina S. Dabaja, MD^8*, Chelsea C. Pinnix, MD, PhD^9*, Jillian R. Gunther, MD, PhD^9*, Hun Lee, MD^10*, Sairah Ahmed, MD¹¹, Raphael Eric Steiner, MD¹⁰, Swaminathan P Iyer, MD¹², Ranjit Nair, MD^12*, Simrit Parmar, M.D., MSCI¹³, Branko Cuglievan, MD^7*, Farzaneh Maadani, BS, MT^1*, Gabriela Rondon³, Richard E. Champlin, MD¹ and Borje S. Andersson, M.D., Ph.D.¹

¹Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
⁵Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
¹²Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Aimaz Afrough, MD¹, Leonard C Alsfeld, MD^1*, Samer A. Srour, MD, MS², Qaiser Bashir, MD², Neeraj Saini, MD², Chitra Hosing, MD¹, Uday R. Popat, MD², Partow Kebriaei, MD¹, Elizabeth J. Shpall, MD¹, Ruby Delgado^1*, Regan Murphy, PA-C^1*, Elisabet E. Manasanch, MD³, Hans C. Lee, MD³, Gregory P. Kaufman, MD^3*, Krina K. Patel, M.D.⁴, Sheeba K. Thomas, MD³, Donna M. Weber, MD³, Robert Z. Orlowski, MD, PhD⁵, Richard E. Champlin, MD¹ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Shebli Atrash, MD¹, Myra Robinson, MSPH^2*, Barry Paul, MD, MS³, Sarah Norek, BSN, RN^4*, David M Foureau, PhD⁵, Carrie Ann Syfert, BSN, RN^4*, Ami P Ndiaye, NP^1*, James T Symanowski, PhD^2*, Jordan Robinson^1*, Manisha Bhutani, MD⁶, Peter M. Voorhees, MD¹ and Saad Z. Usmani, MD, MBBS, MBA⁷

¹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
³Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Charlotte, NC
⁴Clinical Trials, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁶Levine L. Cancer Institute, Charlotte, NC
⁷Levine Cancer Institute, Charlotte, NC

Pranav R Santapuram^1*, Manali Rupji, MS^2*, Michael Graiser, PhD^3*, Edmund K. Waller, PhD, MD⁴, Kristie A. Blum, MD³, Pamela B. Allen, MD, MSc⁵, Jean L. Koff, MD⁶, Leonard Heffner, MD⁷, Mary Jo Lechowicz, MD⁸, Sagar Lonial, MD⁹, Jonathan L. Kaufman, MD⁹, Craig C Hofmeister, MD, MPH³, Madhav V. Dhodapkar, MD¹⁰, Ajay Nooka, MD, MPH³, William Blum, MD¹¹, Rebecca B. Klisovic, MD^12*, Nisha Joseph, MD^3*, Vikas A. Gupta, MD, PhD ¹³, Amelia Langston, MD⁹ and Jonathon B. Cohen, MD, MS¹⁴

¹Internal Medicine, Emory University School of Medicine, Atlanta, GA
²Department of Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory University, Atlatna, GA
³Winship Cancer Institute, Emory University, Atlanta, GA
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
⁵Winship Cancer Institute, Emory University, Assistant Professor, Department of Hematology and Medical Oncology, Attending Physician, Bone Marrow and Stem Cell Transplant Center, Emory University Winship Cancer Institute, Decatur, GA
⁶Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁷Winship Cancer Institute / Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁸Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
⁹Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
¹⁰Emory University School of Medicine, Atlanta, GA
¹¹Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹²Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA
¹³Winship Cancer Institute/ Hematology and Medical Oncology, Emory University, Atlanta, GA
¹⁴Department of Hematology and Medical Oncology, Emory University, Atlanta, GA

Amrita Krishnan, MD¹, Antje Hoering, PhD², Parameswaran Hari, MBBS, MD³, Rachael Sexton, PhD^2* and Robert Z. Orlowski, MD, PhD⁴

¹City of Hope Medical Center, Duarte, CA
²SWOG Statistical Center, Seattle, WA
³Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI
⁴Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Abdullah S. Al Saleh, MBBS¹, Iuliana Vaxman, MD, BA^1*, Harsh Parmar, MD¹, M Hasib Sidiqi, MBBS², Eli Muchtar, MD^1*, Francis K. Buadi, MB, CHB^1*, David Dingli, MD, PhD¹, Martha Q. Lacy, MD¹, Rahma M Warsame, MD³, Wilson I Gonsalves, MD¹, Taxiarchis Kourelis, MD¹, William J Hogan, MB, BCh¹, Prashant Kapoor, MD¹, Robert Wolf, PharmD, RPh^1*, Angela Dispenzieri, MD³, Shaji K. Kumar, MD¹ and Morie Gertz¹

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²Mayo Clinic - Rochester, Perth, WEA, Australia
³Mayo Clinic, Rochester, MN

Kevin Sing, MD¹, Roy Sabo, PhD^2*, James O'Bryan^3*, Matthew Risendal^3*, Catherine H Roberts, PhD^1* and Amir Ahmed Toor, MD^1*

¹Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA
²Department of Biostatistics, Virginia Commonwealth University, Richmond, VA
³Virginia Commonwealth University, Richmond, VA